Postpartum Intervention for Mothers With Opioid Use Disorders (R33)

Recruiting N/A Interventional Study
Opioid Use Disorder Parent-Child Relations
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
80 (estimated)
Sponsor
Stony Brook University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Having met the milestones of the R61, this R33 is a 2-site, 2-group, pre/post RCT of mothers with OUD (n=\~80/group). We will test whether the beneficial pre-post changes in OUD mothers randomized to vMP exceed those of mothers assigned to Enhanced Usual Care (EUC) and via changes in Maternal Brain Neurocircuits.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * mothers with diagnosis of Opioid Use Disorder (OUD); and/or receiving medication assisted treatment (such as buprenorphine or methadone) * with a child aged 5 or less * able to read, hear and understand English adequately enough to provide informed consent Exclusion Criteria:…
Contacts

James E Swain, MD, PhD

516-838-7604

james.swain@stonybrookmedicine.edu

CONTACT

Maria Muzik, MD, MSc

734-846-8027

CONTACT